The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.

CONCLUSION: CEUS has a higher added value compared to early mpMRI in ruling out clinically significant cancer after focal HIFU. It should be evaluated whether the use of CEUS intraoperatively enhances the efficacy of focal HIFU. PMID: 32532530 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32532530?dopt=Abstract

Source: Urologic Oncology - June 8, 2020 Category: Urology & Nephrology Authors: Bacchetta F, Martins M, Regusci S, Jichlinski P, Meuwly JY, Lucca I, Valerio M Tags: Urol Oncol Source Type: research